share_log

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target

HC Wainwright公司重申买入Pacira Biosciences股票,维持目标股价57美元。
Benzinga ·  07/02 13:22

HC Wainwright & Co. analyst Oren Livnat reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $57 price target.

HC Wainwright & Co. 分析师Oren Livnat重申Pacira Biosciences(纳斯达克:PCRX)的买入评级并维持57美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发